Healthcare | June 16, 2022
COVID-19 infected 9-year-child successfully gets a heart transplant at Masinda Heart Institute
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU-approved mRNA Covid-19 vaccine
The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe Covid-19
The licences will allow manufacturers from around the world to work with MPP and C-TAP to make these technologies accessible to people living in low- and middle-income countries
AKS-452 is currently undergoing Phase II/III clinical testing in India as a primary vaccine; submission for Emergency Use Authorization (EUA) expected by Q3 2022
Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19
Subscribe To Our Newsletter & Stay Updated
